CUSIP 28036F105COMEWTXQ4 2025
59 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 15.52M | $385.09M |
| 2 | Ra Capital Management, L.P. | 10.43M | $258.78M |
| 3 | Blackrock, Inc. | 6.63M | $164.54M |
| 4 | Baker Bros. Advisors LP | 6.58M | $163.18M |
| 5 | Paradigm Biocapital Advisors LP | 6.54M | $162.32M |
| 6 | Novo Holdings A/S | 5.35M | $132.76M |
| 7 | Braidwell LP | 5.21M | $129.31M |
| 8 | Vanguard Group Inc | 4.87M | $120.89M |
| 9 |
| 4 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.2% | 5.50M | SEC |
| 5 | Aug 14, 2025 | Baker Bros. Advisors LP | 13G/A | 6.9% | 7.31M | SEC |
| 6 | Aug 14, 2025 | Perceptive Advisors LLC | 13G/A | 4.4% | 4.64M | SEC |
| 7 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 5.5% | 5.82M | SEC |
| 8 | May 15, 2025 | Perceptive Advisors LLC | 13G/A | 6.1% | 6.40M | SEC |
| 9 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.6% | 5.28M | SEC |
| 10 | May 12, 2025 | Orbimed Advisors LLC | 13D/A | 14.5% | — | SEC |
See the full Schedule 13D/13G history for Edgewise Therapeutics Inc.
Unlock full history| Janus Henderson Group PLC |
| 4.57M |
| $113.33M |
| 10 | Siren, L.L.C. | 4.53M | $112.41M |